Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.

Roestenberg M, de Vlas SJ, Nieman AE, Sauerwein RW, Hermsen CC.

J Infect Dis. 2012 Aug 1;206(3):319-23. doi: 10.1093/infdis/jis355. Epub 2012 May 21.

PMID:
22615322
2.

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Bijker EM, Bastiaens GJ, Teirlinck AC, van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, Remarque EJ, Roeffen W, Jansens A, Zimmerman D, Vos M, van Schaijk BC, Wiersma J, van der Ven AJ, de Mast Q, van Lieshout L, Verweij JJ, Hermsen CC, Scholzen A, Sauerwein RW.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7862-7. doi: 10.1073/pnas.1220360110. Epub 2013 Apr 18.

3.
4.

Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.

Sanderson F, Andrews L, Douglas AD, Hunt-Cooke A, Bejon P, Hill AV.

Am J Trop Med Hyg. 2008 Jun;78(6):878-83.

PMID:
18541763
5.

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.

Sherwood JA, Copeland RS, Taylor KA, Abok K, Oloo AJ, Were JB, Strickland GT, Gordon DM, Ballou WR, Bales JD Jr, Wirtz RA, Wittes J, Gross M, Que JU, Cryz SJ, Oster CN, Roberts CR, Sadoff JC.

Vaccine. 1996 Jun;14(8):817-27.

PMID:
8817830
6.

Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.

Hermsen CC, de Vlas SJ, van Gemert GJ, Telgt DS, Verhage DF, Sauerwein RW.

Am J Trop Med Hyg. 2004 Aug;71(2):196-201.

PMID:
15306710
7.
8.

Protection against a malaria challenge by sporozoite inoculation.

Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Rénia L, van der Ven A, Hermsen CC, Sauerwein R.

N Engl J Med. 2009 Jul 30;361(5):468-77. doi: 10.1056/NEJMoa0805832.

9.

The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. I. Development in Aotus lemurinus griseimembra monkeys.

Collins WE, Galland GG, Sullivan JS, Morris CL, Richardson BB, Roberts JM.

Am J Trop Med Hyg. 1996 Apr;54(4):372-9.

PMID:
8615450
10.

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL.

J Infect Dis. 2002 Apr 15;185(8):1155-64. Epub 2002 Apr 1.

PMID:
11930326
11.

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS.

Malar J. 2009 Oct 23;8:235. doi: 10.1186/1475-2875-8-235.

12.

Malaria sporozoite challenge model comes of age.

Stoute JA.

Pathog Glob Health. 2012 Oct;106(6):320. doi: 10.1179/2047772412Z.00000000080. No abstract available.

13.

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

Epstein JE, Rao S, Williams F, Freilich D, Luke T, Sedegah M, de la Vega P, Sacci J, Richie TL, Hoffman SL.

J Infect Dis. 2007 Jul 1;196(1):145-54. Epub 2007 May 29.

PMID:
17538895
14.
16.

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.

Moorthy VS, Diggs C, Ferro S, Good MF, Herrera S, Hill AV, Imoukhuede EB, Kumar S, Loucq C, Marsh K, Ockenhouse CF, Richie TL, Sauerwein RW.

Vaccine. 2009 Sep 25;27(42):5719-25. doi: 10.1016/j.vaccine.2009.07.049. Epub 2009 Aug 3.

PMID:
19654061
17.

Mosquito production mooted as fast track to malaria vaccine.

Butler D.

Nature. 2003 Oct 2;425(6957):437. No abstract available.

PMID:
14523404
18.

Pre-erythrocytic malaria vaccines: towards greater efficacy.

Hill AV.

Nat Rev Immunol. 2006 Jan;6(1):21-32. Review.

PMID:
16493425
19.

Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.

Sina BJ, do Rosario VE, Woollett G, Sakhuja K, Hollingdale MR.

Exp Parasitol. 1993 Sep;77(2):129-35.

PMID:
8375482
20.

Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization.

Nahrendorf W, Spence PJ, Tumwine I, Lévy P, Jarra W, Sauerwein RW, Langhorne J.

Elife. 2015 Feb 25;4. doi: 10.7554/eLife.05165.

Supplemental Content

Support Center